Ovoca Bio plc (AIM:OVB)
London · Delayed Price · Currency is GBP · Price in GBX 1.150
-0.125 (-9.80%)
May 6, 2025, 11:10 AM GMT+1
Ovoca Bio Company Description
Ovoca Bio plc, a clinical-stage biopharmaceutical company, develops and commercializes novel product candidates for women health.
Its lead product is Orenetide, a novel synthetic peptide for premenopausal women with hypoactive sexual desire disorder.
The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
Ovoca Bio plc
| Country | Ireland |
| Founded | 1985 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1 |
| CEO | Timothy McCutcheon |
Contact Details
Address: 17 Pembroke Street Upper Dublin, D02 AT22 Ireland | |
| Phone | 353 1 661 9819 |
| Website | ovocabio.com |
Stock Details
| Ticker Symbol | OVB |
| Exchange | London Stock Exchange AIM |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | IE00B4XVDC01 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Timothy McCutcheon | Chief Executive Officer |
| Leah O'Donovan | Chief Financial Officer |